immunotherapy
Showing 1 - 25 of 40
e-ITAG Allergen Immunotherapy in Management of Allergic Asthma
Recruiting
- Study the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional Treatment
- Immunotherapy
-
Tunis, Montfleury, TunisiaMilitary Hospital of Tunis
Aug 26, 2023
Immunotherapy in MSI-H Metastatic Colorectal Cancer
Recruiting
- Colorectal Cancer
- Immunotherapy
-
Carpi, Modena, ItalyOspedale Ramazzini
Sep 5, 2022
Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)
Recruiting
- Locally Advanced Non-small Cell Lung Cancer
- Efficacy and Safety
- Anlotinib
- +3 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Jul 28, 2022
Organoid Model Predictive of Response to Immunotherapies
Recruiting
- Breast Cancer
- Immunotherapy
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 10, 2023
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Not yet recruiting
- Non-small Cell Lung Cancer
- Immunotherapy
- +2 more
-
Fuzhou, Fujian, China900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022
Anti-Programmed Cell Death Protein 1 Immunotherapy in Head and
Recruiting
- Head and Neck Cancer
- Immunotherapy
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Apr 14, 2022
Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)
Recruiting
- Locally Advanced Non Small Cell Lung Cancer
- Metastatic Non Small Cell Lung Cancer
- SRT
- Immunotherapy
-
Angers, France
- +4 more
Apr 21, 2022
sidE eFfects of ImmuNotherapy:Possible Clue to Optimize cancEr
Recruiting
- Melanoma
- +4 more
- Immunotherapy
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jan 10, 2022
Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)
Recruiting
- Uveal Melanoma
- stereotactic body radiotherapy
- Immunotherapy
-
San Francisco, CaliforniaCalifornia Pacific Medical Center Research Institute
Dec 2, 2022
NSCLC Trial in Chongqing (procedure, drug, radiation)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- bronchial artery interventional therapy
- +3 more
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
May 27, 2023
NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
- radiotherapy
- +3 more
- (no location specified)
Sep 10, 2023
Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- +2 more
- standard Radiotherapy
- +3 more
- (no location specified)
Oct 20, 2023
NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Nutritional intervention
- Immunotherapy
-
Rotterdam, NetherlandsErasmus MC
Jun 5, 2023
Rectal Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (Chemotherapy, Immunotherapy, IMRT)
Active, not recruiting
- Rectal Cancer
- +3 more
- Chemotherapy
- +2 more
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Jun 19, 2021
Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel
Recruiting
- Esophagus Cancer
- +5 more
- Radiotherapy
- +5 more
-
Anyang, Henan, China
- +4 more
Aug 17, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- LDRT+CFRT
- +2 more
-
Shanghai, China
- +1 more
Aug 3, 2023
Melanoma, Melanoma Stage IV, Metastatic Melanoma Trial in Gothenburg (Surgical metastasectomy, Immunotherapy)
Recruiting
- Melanoma
- +3 more
- Surgical metastasectomy
- Immunotherapy
-
Gothenburg, SwedenSahlgrenska University Hospital
May 3, 2022
Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Metastasis directed therapy (MDT)
- +2 more
-
Ghent, BelgiumGhent University Hospital
Dec 3, 2022
NSCLC Stage IV, Brain Metastases, Immunotherapy Trial in Hangzhou (Immunotherapy, WBRT, Chemotherapy)
Recruiting
- NSCLC Stage IV
- +2 more
- Immunotherapy
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 3, 2021
Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- Adaptive Radiotherapy
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 3, 2022
PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC
Recruiting
- Non-small Cell Lung Cancer
- Immunotherapy
-
Monza, ItalyASST-Monza Ospedale San Gerardo
Jun 9, 2022
Brain Metastases, Non Small Cell Lung Cancer Trial in Durham (Stereotactic Radiosurgery, Immunotherapy)
Recruiting
- Brain Metastases
- Non Small Cell Lung Cancer
- Stereotactic Radiosurgery
- Immunotherapy
-
Durham, North CarolinaDuke Cancer Center
Jun 6, 2022
Esophageal Cancer, Gastroesophageal Cancer, Immunotherapy Trial in Jinan (Chemotherapy Drugs, Cancer, Immunotherapy)
Recruiting
- Esophageal Cancer
- +3 more
- Chemotherapy Drugs, Cancer
- Immunotherapy
-
Jinan, Shandong, ChinaThe Second Hospital of Shandong University
Dec 25, 2020
Esophageal Squamous Cell Carcinoma Trial in Hanzhou, Ningbo (Neoadjuvant Radiotherapy, Neoadjuvant Chemotherapy, Immunotherapy)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Neoadjuvant Radiotherapy
- +2 more
-
Hanzhou, Zhejiang, China
- +2 more
Aug 16, 2022
Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)
Not yet recruiting
- Metastatic Tumor
- Palliative Radiotherapy
- +9 more
-
Prince George, British Columbia, Canada
- +2 more
Feb 6, 2023